Dr. David Kimberlin is Vice Chair for Clinical and Translational Research and Co-Director of the Division of Pediatric Infectious Diseases at the University of Alabama at Birmingham. He is Editor of the 2021 American Academy of Pediatrics (AAP) Report of the Committee on Infectious Diseases (Red Book). He also was Editor of the 2018 and 2015 editions, and Associate Editor for the 2009 and 2012 editions. Since 2007, Dr. Kimberlin has served as the AAP Red Book liaison to the CDC Advisory Committee on Immunization Practices (ACIP). He also is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), now known as the Congenital and Perinatal Infections Consortium (CPIC). Funded continuously by NIH/NIAID/DMID since the early 1970s, the CASG/CPIC is a network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika syndrome, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome. Dr. Kimberlin is a Past-President of the Pediatric Infectious Diseases Society (PIDS). In 2016 he received the Ronald McDonald House Charities 2016 Medical Award of Excellence. He has received numerous education awards.